SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-133515
Filing Date
2013-03-29
Accepted
2013-03-29 07:02:01
Documents
11
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d461259d10k.htm 10-K 910096
2 EX-23.1 d461259dex231.htm EX-23.1 1689
3 EX-31.1 d461259dex311.htm EX-31.1 9408
4 EX-32.1 d461259dex321.htm EX-32.1 3646
11 GRAPHIC g461259g13u62.jpg GRAPHIC 39021
  Complete submission text file 0001193125-13-133515.txt   6050892

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rxii-20121231.xml EX-101.INS 710075
6 XBRL TAXONOMY EXTENSION SCHEMA rxii-20121231.xsd EX-101.SCH 64082
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxii-20121231_cal.xml EX-101.CAL 70523
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxii-20121231_def.xml EX-101.DEF 328025
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxii-20121231_lab.xml EX-101.LAB 496538
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxii-20121231_pre.xml EX-101.PRE 384873
Mailing Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581
Business Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54910 | Film No.: 13726178
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences